These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 20230342)

  • 1. Cancer-derived mutations in the fibronectin III repeats of PTPRT/PTPrho inhibit cell-cell aggregation.
    Zhang P; Becka S; Craig SE; Lodowski DT; Brady-Kalnay SM; Wang Z
    Cell Commun Adhes; 2009 Dec; 16(5-6):146-53. PubMed ID: 20230342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-derived extracellular mutations of PTPRT /PTPrho are defective in cell adhesion.
    Yu J; Becka S; Zhang P; Zhang X; Brady-Kalnay SM; Wang Z
    Mol Cancer Res; 2008 Jul; 6(7):1106-13. PubMed ID: 18644975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the adhesive properties of the type IIb subfamily receptor protein tyrosine phosphatases.
    Becka S; Zhang P; Craig SE; Lodowski DT; Wang Z; Brady-Kalnay SM
    Cell Commun Adhes; 2010 Apr; 17(2):34-47. PubMed ID: 20521994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Homophilic adhesion mediated by the neural cell adhesion molecule involves multiple immunoglobulin domains.
    Ranheim TS; Edelman GM; Cunningham BA
    Proc Natl Acad Sci U S A; 1996 Apr; 93(9):4071-5. PubMed ID: 8633018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glial tumor cell adhesion is mediated by binding of the FNIII domain of receptor protein tyrosine phosphatase beta (RPTPbeta) to tenascin C.
    Adamsky K; Schilling J; Garwood J; Faissner A; Peles E
    Oncogene; 2001 Feb; 20(5):609-18. PubMed ID: 11313993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular analysis of receptor protein tyrosine phosphatase mu-mediated cell adhesion.
    Aricescu AR; Hon WC; Siebold C; Lu W; van der Merwe PA; Jones EY
    EMBO J; 2006 Feb; 25(4):701-12. PubMed ID: 16456543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human L1CAM carrying the missense mutations of the fibronectin-like type III domains is localized in the endoplasmic reticulum and degraded by polyubiquitylation.
    Itoh K; Fujisaki K; Watanabe M
    J Neurosci Res; 2011 Oct; 89(10):1637-45. PubMed ID: 21688291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical dissection of Anosmin-1 interaction with FGFR1 and components of the extracellular matrix.
    Murcia-Belmonte V; Esteban PF; García-González D; De Castro F
    J Neurochem; 2010 Dec; 115(5):1256-65. PubMed ID: 20874775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor protein tyrosine phosphatase micro: measuring where to stick.
    Aricescu AR; Siebold C; Jones EY
    Biochem Soc Trans; 2008 Apr; 36(Pt 2):167-72. PubMed ID: 18363557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adaptation of the group A Streptococcus adhesin Scl1 to bind fibronectin type III repeats within wound-associated extracellular matrix: implications for cancer therapy.
    McNitt DH; Choi SJ; Allen JL; Hames RA; Weed SA; Van De Water L; Berisio R; Lukomski S
    Mol Microbiol; 2019 Sep; 112(3):800-819. PubMed ID: 31145503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Site-Directed Mutagenesis of the Fibronectin Domains in Insulin Receptor-Related Receptor.
    Deyev IE; Chachina NA; Zhevlenev ES; Petrenko AG
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29156593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mechanical hierarchies of fibronectin observed with single-molecule AFM.
    Oberhauser AF; Badilla-Fernandez C; Carrion-Vazquez M; Fernandez JM
    J Mol Biol; 2002 May; 319(2):433-47. PubMed ID: 12051919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The TLR4 agonist fibronectin extra domain A is cryptic, exposed by elastase-2; use in a fibrin matrix cancer vaccine.
    Julier Z; Martino MM; de Titta A; Jeanbart L; Hubbell JA
    Sci Rep; 2015 Feb; 5():8569. PubMed ID: 25708982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ShdA adhesin binds to the cationic cradle of the fibronectin 13FnIII repeat module: evidence for molecular mimicry of heparin binding.
    Kingsley RA; Keestra AM; de Zoete MR; Bäumler AJ
    Mol Microbiol; 2004 Apr; 52(2):345-55. PubMed ID: 15066025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the homophilic binding site of the receptor protein tyrosine phosphatase PTP mu.
    Brady-Kalnay SM; Tonks NK
    J Biol Chem; 1994 Nov; 269(45):28472-7. PubMed ID: 7961788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational analysis of PTPRT phosphatase domains in common human cancers.
    Lee JW; Jeong EG; Lee SH; Nam SW; Kim SH; Lee JY; Yoo NJ; Lee SH
    APMIS; 2007 Jan; 115(1):47-51. PubMed ID: 17223850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of development and cancer by the R2B subfamily of RPTPs and the implications of proteolysis.
    Craig SE; Brady-Kalnay SM
    Semin Cell Dev Biol; 2015 Jan; 37():108-18. PubMed ID: 25223585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of regions within the third FnIII-like domain of the IL-5Ralpha involved in IL-5 interaction.
    Czabotar PE; Holland J; Sanderson CJ
    Cytokine; 2000 Jul; 12(7):867-73. PubMed ID: 10880230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sequence conservation in Ig-like domains: the role of highly conserved proline residues in the fibronectin type III superfamily.
    Steward A; Adhya S; Clarke J
    J Mol Biol; 2002 May; 318(4):935-40. PubMed ID: 12054791
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The heparin III-binding domain of fibronectin (III4-5 repeats) binds to fibronectin and inhibits fibronectin matrix assembly.
    Maqueda A; Moyano JV; Hernández Del Cerro M; Peters DM; Garcia-Pardo A
    Matrix Biol; 2007 Oct; 26(8):642-51. PubMed ID: 17611093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.